Potentially Harmful Drug-Disease Interactions in the Elderly: the Percentage of Those With Dementia That Received a Potentially Harmful Medication
Identifying Attributes
Care Settings
Primary Care
Country
United States of America
Publishing Organisation
public reporting, Quality Improvement with Benchmarking (external benchmarking to multiple organizations), Regulatory and Accreditation Programs
Type of Quality Indicator
Outcome
IOM Quality Dimension
Safety
Domain
Medications and Medication Management
Defining Attributes
Definition
The percentage of patients 65 years of age and older with dementia who are dispensed an ambulatory prescription for a potentially harmful medication, concurrent with or after the diagnosis.
Numerator
Patients with a diagnosis of dementia who received at least one potentially harmful medication from Table DDE-D
Denominator
All patients 65 years of age and older with a diagnosis of dementia in the measurement year or the year prior to the measurement year.
Exclusions
Diagnosis of psychosis, schizophrenia, schizoaffective disorder or bipolar disorder.
Use of Risk Adjustment
No
Risk Adjustments
None
Stratifications
None
Collection and Reporting Attributes
Type of Data Collection
Administrative data
Data Collection Methods
Claims data
Frequency of Data Collection
Frequency of Data Collection in Days
Reporting Methods
Reporting Frequency
Reporting Frequency in Days
Indicator Has Recommended Targets
No
Source and Reference Attributes
Evidence Source
Technical Specifications
Link to Measurement Tools
Quality Indicator Confirmed to be Part of a Program Used to Monitor Quality and Safety of Care Among Older People at a Population-Level between 2012-2022
Yes
Assessed by the Australian Consortium for Aged Care Collaborators as Generally Containing Good Properties (Importance and Scientific Acceptability)
Yes
Australian Consortium for Aged Care Endorsed
Yes
Identified by PHARMA-Care Project
No
Upload Date
02 December 2025
Contents
Actions
Date Modified 02 December 2025